Cargando…
Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells
BACKGROUND: The majority of glioblastomas have aberrant receptor tyrosine kinase (RTK)/RAS/phosphoinositide 3 kinase (PI3K) signaling pathways and malignant glioma cells are thought to be addicted to these signaling pathways for their survival and proliferation. However, recent studies suggest that...
Autores principales: | Shingu, Takashi, Holmes, Lindsay, Henry, Verlene, Wang, Qianghu, Latha, Khatri, Gururaj, Anupama E., Gibson, Laura A., Doucette, Tiffany, Lang, Frederick F., Rao, Ganesh, Yuan, Liang, Sulman, Erik P., Farrell, Nicholas P., Priebe, Waldemar, Hess, Kenneth R., Wang, Yaoqi A., Hu, Jian, Bögler, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746796/ https://www.ncbi.nlm.nih.gov/pubmed/26861698 http://dx.doi.org/10.1186/s12967-016-0803-2 |
Ejemplares similares
-
“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014) -
Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors
por: Marusiak, Anna A., et al.
Publicado: (2014) -
Conferring specificity on the ubiquitous Raf/MEK signalling pathway
por: O'Neill, E, et al.
Publicado: (2004) -
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020) -
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
por: Atefi, Mohammad, et al.
Publicado: (2015)